Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis
Morrissey, Orla
(Primary Chief Investigator (PCI))
Infectious Diseases
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
23/01/24
→
23/01/26
View all
View less
Keywords
clinical trial
pulmonary aspergillosis
antifungal therapy
PC945